No Data
No Data
Express News | Lilly CEO to CNBC-TV18: Possibility of Manufacturing Mounjaro in India
Eli Lilly Could See Higher Q1 Sales for Zepbound, UBS Says
Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Press Release: Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
Express News | Organovo Announces Close of the Sale of Fxr Program to Eli Lilly and Company